Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Goldberg, Natalia ^a   Kundel, Yulia ^a,b   Purim, Ofer ^a,b   Bernstine, Hanna ^a   Gordon, Noa ^a   Morgenstern, Sara ^a,b   Idelevich, Efraim ^c   Wasserberg, Nir ^a,b   Sulkes, Aaron ^a,b   Groshar, David ^a,b,d   Brenner, Baruch ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c KAPLAN MEDICAL CENTER   (Israel)

^d ASSUTA MEDICAL CENTER   (Israel)

Author keywords

PET CT; Radiochemotherapy; Rectal cancer

Indexed keywords

CAPECITABINE; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; IOPROMIDE; MEGLUMINE IOXITALAMATE PLUS SODIUM IOXITALAMATE; UFT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTINUOUS INFUSION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOCALLY ADVANCED RECTAL CANCER; MALE; METABOLISM; MULTIMODALITY CANCER THERAPY; PREDICTION; PREDICTIVE VALUE; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PROSPECTIVE STUDY; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM ANTERIOR RESECTION; RECTUM CANCER; RECTUM SURGERY; SENSITIVITY AND SPECIFICITY; TOTAL MESORECTAL EXCISION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; DEOXYCYTIDINE; FEMALE; FLUORODEOXYGLUCOSE F18; FLUOROURACIL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; TEGAFUR; URACIL;

EID: 84866497365     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-124     Document Type: Article

References (27)

1. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ, . Dutch Colorectal Cancer Group Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646. 10.1056/NEJMoa010580, 11547717, Dutch Colorectal Cancer Group.
2. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, . German Rectal Cancer Study Group Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740. 10.1056/NEJMoa040694, 15496622, German Rectal Cancer Study Group.
3. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC, . EORTC Radiotherapy Group Trial 22921 Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123. 10.1056/NEJMoa060829, 16971718, EORTC Radiotherapy Group Trial 22921.
4. Valentini V, Coco C, Cellini N, Picciocchi A, Fares MC, Rosetto ME, Mantini G, Morganti AG, Barbaro B, Cogliandolo S, Nuzzo G, Tedesco M, Ambesi-Impiombato F, Cosimelli M, Rotman M. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: Acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001, 51:371-383.
5. Capirci C, Rubello D, Chierichetti F, Crepaldi G, Fanti S, Mandoliti G, Salviato S, Boni G, Rampin L, Polico C, Mariani G. Long-term prognostic value of 18 F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy. Am J Roentgenol 2006, 187:W202-W208.
6. Garcia-Aguilar J. Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA: A pathological complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision and chemotherapy. Ann Surg 2002, 236:75-81. 10.1097/00000658-200207000-00012, 1422551, 12131088.
7. Rödel C, Martus P, Papadoupolos T, Füzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005, 23:8688-8696. 10.1200/JCO.2005.02.1329, 16246976.
8. Rosenberg R, Nekarda H, Zimmerman F, Becker K, Lordick F, Hofler H, Molls M, Siewert JR. Histopathological response after neoadjuvant radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol 2008, 97:8-13. 10.1002/jso.20844, 18085619.
9. Kalff V, Duong C, Drummond EG, Matthews JP, Hicks RJ. Findings on 18 F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. J Nucl Med 2006, 47:14-22.
10. Denecke T, Rau B, Hoffman KT, Hildebrandt B, Ruf J, Gutberlet M, Hünerbein M, Felix R, Wust P, Amthauer H. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging?. Eur Radiolol 2005, 15:1658-1666.
11. Guillem JG, Moore HG, Akhurst T, Klimstra DS, Ruo L, Mazumdar M, Minsky BD, Saltz L, Wong WD, Larson S. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: A means for determining long term outcomes of rectal cancer. J Am Coll Surg 2004, 199:1-7.
12. Melton GB, Lavely WC, Jacene HA, Schulick RD, Choti MA, Wahl RL, Gearhart SL. Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg 2007, 11:961-969. 10.1007/s11605-007-0170-7, 17541799.
13. Cascini GL, Avallone A, Delrio P, Guida C, Tatangelo F, Marone P, Aloj L, De Martinis F, Comella P, Parisi V, Lastoria S. 18 F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 2006, 47:1241-1248.
14. Janssen MH, Ollers MC, Riedl RG, van den Bogaard J, Buijsen J, van Stiphout RG, Aerts HJ, Lambin P, Lammering G. Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography- computed tomography imaging. Int J Radiat Oncol Biol Phys 2010, 77:392-399. 10.1016/j.ijrobp.2009.04.030, 19646825.
15. Rosenberg R, Herrmann K, Gertler R, Künzli B, Essler M, Lordick F, Becker K, Schuster T, Geinitz H, Maak M, Schwaiger M, Siewert JR, Krause B. The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT. Int J Colorectal Dis 2009, 24:191-200. 10.1007/s00384-008-0616-8, 19050900.
16. Guerra L, Niespolo R, Di Pisa G, Ippolito D, De Ponti E, Terrevazzi S, Bovo G, Sironi S, Gardani G, Messa C. Change in glucose metabolism measured by 18 F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer. Abdom Imaging 2011, 36:38-45. 10.1007/s00261-009-9594-8, 20033405.
17. Lambrecht M, Deroose C, Roels S, Vandecaveye V, Penninckx F, Sagaert X, van Cutsem E, de Keyzer F, Haustermans K. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. Acta Oncol 2010, 49:956-963. 10.3109/0284186X.2010.498439, 20586658.
18. Leibold T, Akhurst TJ, Chessin DB, Yeung HW, Macapinlac H, Shia J, Minsky BD, Saltz LB, Riedel E, Mazumdar M, Paty PB, Weiser MR, Wong WD, Larson SM, Guillem JG. Evaluation of (18)F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis. Ann Surg Oncol 2011, 18:2783-2789. 10.1245/s10434-011-1634-2, 21476107.
19. Janssen MH, Ollers MC, van Stiphout RG, Riedl RG, van den Bogaard J, Buijsen J, Lambin P, Lammering G. PET-based treatment response evaluation in rectal cancer: prediction and validation. Int J Radiat Oncol Biol Phys 2011, 82:871-876.
20. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. Colon and rectum 2010, 143-164. Springer, New York, NY, Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G, 7.
21. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer 1994, 73:2680-2686. 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C, 8194005.
22. Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, Miccichè F, Ricci R, Morganti AG, Gambacorta MA, Maurizi F, Coco C. The relationship of pathological tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Bio Phys 2005, 62:752-760.
23. Bujko K, Kolodziejczyk M, Nasierowska-Guttmejer A, Michalski W, Kepka L, Chmielik E, Wojnar A, Chwalinski M, . Polish Colorectal Cancer Group Tumor regression grading in patients with residual rectal cancer after preoperative chemoradiation. Radiother Oncol 2010, 95:298-302. 10.1016/j.radonc.2010.04.005, 20430458, Polish Colorectal Cancer Group.
24. Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, Pruim J, Price P. Measurement of clinical and subclinical tumour response using [18 F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 1999, 35:1773-1782. 10.1016/S0959-8049(99)00229-4, 10673991.
25. Becker K, Muller JD, Schumacher C, Ott K, Fink U, Busch R, Böttcher K, Siewert JR, Höfler H. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 2003, 98:1521-1530. 10.1002/cncr.11660, 14508841.
26. Garcia-Aguilar J, Hernandez de Anda E, Sirivong P, Lee SH, Madoff RA, Rothenberger DA. A pathologic complete response to preoperative chemoradiaton is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003, 46:298-304. 10.1007/s10350-004-6545-x, 12626903.
27. Ruo L, Tickoo S, Klimstra DS, Minsky BD, Saltz L, Mazumdar M, Paty PB, Wong WD, Larson SM, Cohen AM, Guillem JG. Long term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 2002, 236:75-81. 10.1097/00000658-200207000-00012, 1422551, 12131088.